Effect of clopidogrel added to aspirin in patients with atrial fibrillation.
about
ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD - SummaryCONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trialsStroke prevention in atrial fibrillation: latest clinical trials and guidelinesDouble or triple antithrombotic combination therapy in patients who need anticoagulation and antiplatelet therapy in parallelChallenges and Treatment for Stroke Prophylaxis in Patients with Atrial Fibrillation in Mexico: A ReviewStroke Event Rates and the Optimal Antithrombotic Choice of Patients With Paroxysmal Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsAntithrombotic management of atrial fibrillation in the elderlyManaging anticoagulation for atrial fibrillation: current issues and future strategiesEffect of addition of clopidogrel to aspirin on mortality: systematic review of randomized trialsAn evidence-based review of edoxaban and its role in stroke prevention in patients with nonvalvular atrial fibrillationSystematic review and network meta-analysis of stroke prevention treatments in patients with atrial fibrillation.2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society.Non-vitamin K antagonist oral anticoagulants and atrial fibrillation guidelines in practice: barriers to and strategies for optimal implementationGuidelines on oral anticoagulation with warfarin - fourth editionPharmacogenomics and Global Precision Medicine in the Context of Adverse Drug Reactions: Top 10 Opportunities and Challenges for the Next DecadeEffects of combined aspirin and clopidogrel therapy on cardiovascular outcomes: a systematic review and meta-analysisEpidemiology, Risk Factors, and Clinical Features of Intracerebral Hemorrhage: An Update.Detecting nonvalvular atrial fibrillation and anticoagulant therapy in cardioembolic ischemic stroke.Direct anticoagulant drugs to overcome limitations of vitamin K antagonists. A critical appraisal of data in atrial fibrillation patients.The Secondary Prevention of Small Subcortical Strokes (SPS3) study.Platelet-oriented inhibition in new TIA and minor ischemic stroke (POINT) trial: rationale and design.Cardiovascular outcomes during treatment with dabigatran: comprehensive analysis of individual subject data by treatment.Stroke prevention in atrial fibrillation: established oral anticoagulants versus novel anticoagulants-translating clinical trial data into practice.Antithrombotic therapy and outcomes after ICD implantation in patients with atrial fibrillation and coronary artery disease: an analysis from the National Cardiovascular Data Registry (NCDR)®.Oral antiplatelet therapy for acute and chronic management of NSTE ACS: residual ischemic risk and opportunities for improvement.Antiplatelet Therapy Combinations and Thrombogenicity in Patients with Non-Valvular Atrial Fibrillation.Atrial fibrillation: the current epidemicEffects of clopidogrel added to aspirin in patients with recent lacunar strokeUpdate on antithrombotic therapy for stroke prevention in atrial fibrillation.HRS policy statement: clinical cardiac electrophysiology fellowship curriculum: update 2011Guided antithrombotic therapy: current status and future research direction: report on a National Heart, Lung and Blood Institute working group.Risk analysis of new oral anticoagulants for gastrointestinal bleeding and intracranial hemorrhage in atrial fibrillation patients: a systematic review and network meta-analysis.Feasibility of TEE-guided stroke risk assessment in atrial fibrillation-background, aims, design and baseline data of the TIARA pilot studyAnticoagulation in Patients Aged ≥75 years with Atrial Fibrillation: Role of Novel Oral Anticoagulants.Efficacy and safety of adding clopidogrel to aspirin on stroke prevention among high vascular risk patients: a meta-analysis of randomized controlled trials.'Ins' and 'outs' of triple therapy: Optimal antiplatelet therapy in patients on chronic oral anticoagulation who need coronary stenting.Effect of pharmacological therapies for stroke prevention on major gastrointestinal bleeding in patients with atrial fibrillation.Antithrombotic therapy in cardiac embolism.Present concepts in management of atrial fibrillation: From drug therapy to ablation.Dual antiplatelet therapy in secondary prevention of ischemic stroke: a ghost from the past or a new frontier?
P2860
Q22241786-171A1BD8-EE4D-4DC0-8E8F-CCF1DC1E93CAQ24614627-9C8915DC-2F03-4712-9100-4369C2B32644Q24628390-6DC218B3-A4A4-4638-8C40-F32D1C06DD88Q26741058-B39DE886-4030-4D24-8544-FDB8E88CF674Q26765949-968CFD69-D6CE-4F61-A537-414BB9D4CC0DQ26771564-A4EB842E-41DA-4966-BB93-4A6EEE27FE1CQ26827113-839AE0B4-6079-407D-AD76-4D5353EACAADQ26991728-734C344F-3A13-4D70-B4D4-97956C4E0DC5Q26999848-005EEADF-7EA5-4A08-B098-96ED7423EC1BQ27027953-EAFD94C1-34BE-45AE-91A5-67137BB0A9F0Q27337981-10F04BEA-41A4-466F-898D-90FD0F9213ECQ27341873-2877300D-0416-41E0-8209-A6504CC9F32BQ28087146-1FFAA75A-F929-4B46-BE71-636F27D0821FQ28240666-C01DEDEE-9505-4670-BFF5-07446F4A227BQ28392069-1D48FA1B-7D06-439A-ABBD-BA3DBF8525B1Q28480610-A80F6E18-DE32-46D4-916B-558A892C635AQ30238502-454AC966-83D6-4E7F-8C35-A419DAB831CFQ30249817-F8215AB5-CB91-4E7B-A5BF-2D6C9C4EAAB9Q30595943-43CCF7A4-D2D7-4A19-BAB3-70CACF4C1A3EQ30596571-E07950F3-4616-4FF0-BFC7-AD3AD2025E12Q30644831-DD914C8A-45B9-4B1D-B716-97A4D05AE1C1Q30680968-366EFAC4-543F-4BB7-9C02-C97CE2E3BDE4Q30827866-4FAC2D02-EE68-406F-AEF4-C4211DCFC29AQ30886769-D2C0C024-EC32-42C8-8BCD-7D864B4B73F0Q33554381-A2A74BB0-F44D-4676-A114-80EBDE5EEE27Q33740815-56F99330-F64E-4BA6-8F87-FA5E93AE4584Q33766896-A3615E77-4A44-45B9-9267-0BB393023826Q33792318-9A4FC883-7B90-4BFE-9B41-EF67078A45BFQ33814131-427745E7-C4CD-429D-A245-532E362947E3Q33815633-61813F3C-980F-4E93-B655-74D0D57869CAQ33863833-DA1EF60B-752D-4EF0-A6F9-84D10CD8E0B8Q33876319-DE000155-E500-4CF4-B94B-036A841C0BDFQ33889600-A5821C52-D66F-4F9C-8849-94174872315EQ33936087-397C3D62-E7F5-4A6F-B3B2-B4C8C7C92887Q34028223-3FDFE395-EF64-4B3A-9FC1-16E27DEAC6B3Q34135274-612762DC-8A17-4EB7-9B74-83AAB9127F53Q34233473-D041E10C-75AD-4C2B-B107-A0784F3519AAQ34362901-F9CC2838-A57E-46C5-B181-FD6557ACC442Q34389483-C5E7981C-D674-4907-8F5A-A7D2DF6312A0Q34479105-85CC6FD3-43C7-47D3-821E-F1F6757A2B57
P2860
Effect of clopidogrel added to aspirin in patients with atrial fibrillation.
description
2009 nî lūn-bûn
@nan
2009 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մարտին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Effect of clopidogrel added to aspirin in patients with atrial fibrillation.
@ast
Effect of clopidogrel added to aspirin in patients with atrial fibrillation.
@en
Effect of clopidogrel added to aspirin in patients with atrial fibrillation.
@nl
type
label
Effect of clopidogrel added to aspirin in patients with atrial fibrillation.
@ast
Effect of clopidogrel added to aspirin in patients with atrial fibrillation.
@en
Effect of clopidogrel added to aspirin in patients with atrial fibrillation.
@nl
prefLabel
Effect of clopidogrel added to aspirin in patients with atrial fibrillation.
@ast
Effect of clopidogrel added to aspirin in patients with atrial fibrillation.
@en
Effect of clopidogrel added to aspirin in patients with atrial fibrillation.
@nl
P2093
P50
P921
P356
P1476
Effect of clopidogrel added to aspirin in patients with atrial fibrillation.
@en
P2093
ACTIVE Investigators
Marc Pfeffer
Robert G Hart
Stefan H Hohnloser
Stuart J Connolly
P304
P356
10.1056/NEJMOA0901301
P407
P577
2009-03-31T00:00:00Z